BioSpace News Archive

Bright Minds Biosciences today announced that Ian McDonald, Chief Executive Officer, and Dr. Gideon Shapiro Ph.D, Vice President of Discovery, will be presenting at the H.C. Wainwright Virtual Conference.

atai Life Sciences B.V. today announced the commencement of a proposed underwritten initial public offering of 14,286,000 of its common shares.

Encore Healthcare announces staggering results from their new oxygen and nebulizer management Nexus TeleRespiratory Care model.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced a research collaboration agreement with Mayo Clinic to conduct human clinical proof of concept studies using the Sofusa Lymphatic Drug Delivery System (S-LDDS) technology across multiple products and indications

Stuart Therapeutics, Inc. (“Stuart”), a clinical stage biopharmaceutical company conducting research and development of unique peptide therapeutics for ophthalmic diseases, today announced the start of patient enrollment for the company’s Phase 2 study of ST-100, in Dry Eye Eisease patients.

New data from Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) for valemetostat, a potential first-in-class specific and potent dual inhibitor of EZH1 and EZH2, showed promising and durable tumor response in patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) and adult T-cell leukemia/lymphoma (ATL)

Increasing launch of cost-efficient generic epinephrine products, growing incidence of anaphylaxis, and rising demand for epinephrine injections to treat cardiac arrest and asthma are some key factors driving market growth.

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.

According to The Insight Partners market research study of Creatinine Measurement Market to 2027 - Global Analysis and Forecasts by Product, Type, Sample Type, and End User.

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve cost, efficiency, and outcomes of surgical procedures, today announced that Adam Sachs, the Chief Executive Officer of Vicarious Surgical, will participate in the Cowen 6th Annual FutureHealth Conference,